The orphan drugs market which is USD 174.11 billion in 2022, is expected to reach USD 359.86 billion by 2030, at a CAGR of 9.5% during the forecast period 2023 to 2030.
Market Definition
Orphan drugs are medical products intended to prevent, diagnose, or treat rare, life-threatening disorders. These are known as orphan drugs because the pharmaceutical industry has little interest in developing and marketing these products for a small number of patients under normal market conditions.
Global Orphan Drugs Market Scope
The orphan drugs market is segmented on the basis of drug type, disease type, indication type, drug type, sale, therapy class and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Get full Access of Sample Report:- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-orphan-drugs-market
Drug Type
· Biological
· Non-Biological
Disease Type
· Oncologic Diseases
· Metabolic Disease
· Hematologic and Immunologic Diseases
· Infectious Diseases
· Neurological Diseases
· Others
Indication Type
· Non-Hodgkin Lymphoma
· Acute Myeloid Leukemia
· Cystic Fibrosis
· Glioma
· Pancreatic Cancer
· Ovarian Cancer
· Multiple Myeloma
· Duchenne Muscular Dystrophy
· Renal Cell Carcinoma
· Graft Vs Host Disease
· Others
Drug Type
· Revlimid
· Rituxan
· Opdivo
· Keytruda
· Imbruvica
· Soliris
· Jakaf
· Pomalyst
· Darzalex
· Spinraza
· Adcetris
Sale
· Generics
· Prescribed
Therapy Class
· Oncology
· Blood
· Central Nervous Systems
· Endocrine
· Cardiovascular
· Respiratory
Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Sales
· Others
Orphan Drugs Market Regional Analysis/Insights
The orphan drugs market is analyzed and market size insights and trends are provided by country, drug type, disease type, indication type, drug type, sale, therapy class and distribution channel as referenced above.
The countries covered in the orphan drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the orphan drugs market due to high prevalence of rare disorders.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the developing healthcare infrastructure, as well as the high prevalence of other diseases such as endocrinology, cardiovascular and lymphatic systems, and respiratory disorders.
MAJOR TOC OF THE REPORT
Chapter One: - Segmentation
Chapter two: - Market Definition
Chapter Three: - Market Scope
Get toc details:- https://www.databridgemarketresearch.com/toc/?dbmr=global-orphan-drugs-market
Browse Related Reports
Europe Healthcare IT Outsourcing Market
Europe Healthcare Information Technology (IT) Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek